Going Beyond Together - Caring for Type 1

Partnership objectives

Gather data and information on the coverage, cost and care (“3Cs”) of Type 1 diabetes disease in China.

Increase local and national awareness on the need to improve care for people with Type 1 diabetes.  

Working closely with Chinese Daibetes Society, the IDF, and the Ministery of Health was a good example of partnership to better understand and characterise the disease. Working closely with Chinese Daibetes Society, the IDF, and the Ministery of Health was a good example of partnership to better understand and characterise the disease. Copyright Sanofi

What are the health needs and challenges?

Type 1 diabetes is a form of diabetes mellitus that results from autoimmune destruction of insulin-producing beta cells of the pancreas. The disease is fatal unless treated with multiple injection of insulin daily such as Basal Bolus or continuous infusion of insulin for the life time. The disease is often diagnosed in individuals of young age, and people with Type 1 diabetes risk suffering from complications such as blindness, kidney failure, heart disease, or amputation if the disease is not well controlled.

Description of partnership activities and how they address needs and challenges

The study aims to gather data and information on the coverage, cost and care for people with Type 1 diabetes in China. The results will be used to increase the awareness for improving T1D in china and to make a call for action. The ‘3C Study on Type 1 Diabetes in China’ was carried out in Beijing and Shantou, Guangdong Province, at primary, secondary, and tertiary healthcare institutions, and the results have been presented at the World Diabetes Congress in December 2011 in Dubai.

Lessons learned               

The conduction of a situation analysis of the disease in those 2 regions in China was a very important steps for the project as it helps to identify the existing gaps.

Working closely with Chinese Diabetes Society, IDF, and the Ministery of Health, this was a good example of partnership to better understand and characterise the disease. An appropriate action plan was then easy to propose and to be endorsed by the 3 parties.

Partnership information

Company(ies) Sanofi

Partner(s) Chinese Diabetes Society, International Diabetes Federation (IDF)

Type of Partner(s) Government, NGOs

Therapeutic Focus Non-Communicable Diseases

Disease(s) Diabetes

Program Type(s) Prevention Programs - Awareness & Outreach

Targeted Population(s) Children, Men, Patients in needs of treatment, Women, Youth

Region(s) East Asia & Pacific

Number of Countries 1

Country(ies) China

Start Date 2011

More information International Diabetes Federation

Completed date 2015

« ...A new milestone in the fight against Type 1 diabetes in China and worldwide. It aims to describe critical components of Type 1 diabetes such as coverage, disease burden, health economics, and status of care. »

Professor Jean-Claude Mbanya, President of IDF